US clinical trial results show that a treatment regimen developed specifically for children with acute lymphoblastic leukaemia, (ALL), is also effective for treating older adolescents and young adults with the disease, though patients in the study who were obese or very obese had significantly worse outcomes than other patients.
Haematologist Dr Wendy Stock of the Leukaemia and Lymphoma Society, who was involved in the collaborative trial at the University of Chicago Medicine, said: ‘There’s been tremendous progress in the treatment of ALL, but we still have challenges ahead in terms of further improving survival and decreasing side effects for young adults with the disease. Our next generation of trials are already aiming towards these goals.’
Acute Lymphoblastic Leukaemia, (ALL).
Young Lives vs Cancer
What is Leukaemia?